Hangzhou AGS MedTech Co., Ltd. (SHA:688581)

Hangzhou AGS MedTech Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	1,045	1,177	1,032	1,955	213.38	204.53
Short-Term Investments	-	196.57	81.2	-	-	-
Trading Asset Securities	928.3	592.42	671.22	82.42	55.01	1.09
Cash & Short-Term Investments	1,974	1,966	1,784	2,037	268.4	205.62
Cash Growth	13.38%	10.20%	-12.42%	659.01%	30.53%	32.06%
Accounts Receivable	37.88	60.54	48.15	58.51	18.83	12.24
Other Receivables	1.66	-	-	1.18	2.11	2.04
Receivables	39.54	60.54	48.15	59.68	20.95	14.28
Inventory	57.03	59.65	56.38	46.8	38.57	39.89
Prepaid Expenses	-	-	-	0.05	0.1	-
Other Current Assets	319.66	7.85	5.76	2.45	3.88	2.78
Total Current Assets	2,390	2,094	1,894	2,146	331.89	262.56
Property, Plant & Equipment	240.93	201.27	200.09	159.7	117.67	54.89
Long-Term Investments	35.7	316.67	432.43	-	-	-
Other Intangible Assets	47.55	48.45	18.27	19	19.72	19.95
Long-Term Deferred Tax Assets	1.5	2.14	1.24	1.9	0.36	0.3
Long-Term Deferred Charges	3.36	3.9	2.77	2.35	3.3	3.18
Other Long-Term Assets	19.29	10.12	0.58	1.99	0.19	1.12
Total Assets	2,738	2,677	2,550	2,331	473.13	341.99

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	56.67	40.6	66.02	48.41	32.05	37.65
Accrued Expenses	27.02	32.9	40.84	34.79	24.29	9.13
Short-Term Debt	52.04	35	-	-	-	-
Current Portion of Leases	-	1.41	1.3	0.57	1.08	0.94
Current Income Taxes Payable	5.06	9.71	17.49	14.95	15.7	6.95
Current Unearned Revenue	11.44	12.66	8.28	5.14	7.15	8.77
Other Current Liabilities	6.07	19.61	8.05	16.88	10.76	5.56
Total Current Liabilities	159.38	151.9	141.99	120.73	91.03	69
Long-Term Leases	-	0.85	2.15	-	0.57	1.39
Long-Term Unearned Revenue	6.93	7.61	8.53	2.1	-	-
Long-Term Deferred Tax Liabilities	0.01	0.01	-	-	-	0.16
Total Liabilities	166.32	160.37	152.67	122.83	91.59	70.55

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	80.74	81.12	80.98	57.87	43.4	43.4
Additional Paid-In Capital	1,705	1,716	1,725	1,715	76.53	76.53
Retained Earnings	791.25	732.38	621.87	434.79	261.54	151.62
Treasury Stock	-1.07	-13.65	-30.97	-	-	-
Comprehensive Income & Other	-4.83	1.17	0.1	0.11	0.07	-0.1
Total Common Equity	2,572	2,517	2,397	2,208	381.54	271.45
Minority Interest	0.47	-0.47	-	-	-	-
Shareholders' Equity	2,572	2,516	2,397	2,208	381.54	271.45
Total Liabilities & Equity	2,738	2,677	2,550	2,331	473.13	341.99

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	53.12	37.26	3.45	0.57	1.64	2.32
Net Cash (Debt)	1,921	1,929	1,781	2,037	266.75	203.3
Net Cash Growth	10.49%	8.32%	-12.57%	663.48%	31.21%	30.57%
Net Cash Per Share	23.93	23.97	22.10	28.06	4.39	3.35
Filing Date Shares Outstanding	80.39	81.1	80.58	81.02	60.76	60.76
Total Common Shares Outstanding	80.39	81.1	80.58	81.02	60.76	60.76
Working Capital	2,231	1,942	1,752	2,025	240.86	193.57
Book Value Per Share	31.99	31.03	29.75	27.26	6.28	4.47
Tangible Book Value	2,524	2,468	2,379	2,189	361.82	251.5
Tangible Book Value Per Share	31.40	30.43	29.52	27.02	5.95	4.14
Buildings	-	166.44	164.61	71.12	26.84	26.84
Machinery	-	62.09	52.19	41.56	7.7	28.88
Construction In Progress	-	8.93	8.65	67.92	72.65	10.55

Data Source: S&P Global Market Intelligence Last updated: Oct 28, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 9, 2026

Data Sources Report a data error